Transmedics Group Inc (TMDX)

$64.18 +0.25 (0.39%)
Market Cap 2.22B
Revenue (ttm) 605.49M
Net Income (ttm) 190.29M
EPS (ttm) N/A
PE Ratio 27.69
Forward PE 32.68
Profit Margin 31.43%
Debt to Equity Ratio 0.12
Volume 2,276,400
Avg Vol 1,245,598
Day's Range N/A - N/A
Shares Out 34.56M
Stochastic %K 3%
Beta 2.07
Analysts Strong Sell
Price Target $119.89

Company Profile

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 552 0900
Address:
200 Minuteman Road, Suite 302, Andover, United States
Gemology
Gemology May. 13 at 9:37 PM
$HUT $SLNH $TMDX $FTNT $KULR think
0 · Reply
BonprixUltimateGuardians
BonprixUltimateGuardians May. 13 at 8:07 PM
$MBAI $TMDX $DUOL $FSLY home
0 · Reply
john565
john565 May. 13 at 7:52 PM
$TMDX only works as a small position. Otherwise the volatility will mess with your head
1 · Reply
approved_13
approved_13 May. 13 at 7:41 PM
$TMDX here long term not calling under 120$ loaded 500 shares on today’s discount.
0 · Reply
rel5
rel5 May. 13 at 7:19 PM
$TMDX amazing move today, great setup $META $SOFI $BABA
0 · Reply
danieltanner
danieltanner May. 13 at 7:14 PM
$TMDX anyone read their comments for the OpO proposed rule? So well done! Certainly a big catalyst
1 · Reply
undyingzor
undyingzor May. 13 at 6:38 PM
$TMDX eps down yesr over year, quarter to quarter. It's no longer the hyper growth compsny we are used to, and may not even be a groeth company. The sector has a solid based butbshould notnbe pricing as such high prices. A p/e of 10 or around $44/share is a fair value
1 · Reply
danieltanner
danieltanner May. 13 at 6:29 PM
$TMDX how many long-term holders got shaken out of his name? How many will regret the institutions taking their shares? People complain about “the rich” get richer. They simply don’t get shaken out and look long term. We got this team!
0 · Reply
yourock
yourock May. 13 at 6:00 PM
$TMDX time to buy? 2B market cap sounds reasonable
0 · Reply
buylowandwait
buylowandwait May. 13 at 5:47 PM
$TMDX Bought more today. I don’t see fundamental shift that deserves 50% haircut. Just look at historical price, this will bounce back, once it does, it will do so violently LoL
0 · Reply
Latest News on TMDX
TransMedics downgraded to Perform from Outperform at Oppenheimer

2026-05-07T09:26:03.000Z - 6 days ago

TransMedics downgraded to Perform from Outperform at Oppenheimer

TransMedics price target lowered to $140 from $157 at Baird

2026-05-07T09:04:08.000Z - 6 days ago

TransMedics price target lowered to $140 from $157 at Baird

TransMedics price target lowered to $85 from $130 at Stifel

2026-05-07T07:51:01.000Z - 6 days ago

TransMedics price target lowered to $85 from $130 at Stifel

TransMedics price target lowered to $124 from $152 at Canaccord

2026-05-07T06:59:58.000Z - 6 days ago

TransMedics price target lowered to $124 from $152 at Canaccord

TransMedics price target lowered to $120 from $190 at TD Cowen

2026-05-07T05:04:44.000Z - 6 days ago

TransMedics price target lowered to $120 from $190 at TD Cowen

TransMedics price target lowered to $142 from $174 at Needham

2026-05-07T03:53:35.000Z - 6 days ago

TransMedics price target lowered to $142 from $174 at Needham

TransMedics falls -20.5%

2026-05-07T03:40:51.000Z - 6 days ago

TransMedics falls -20.5%

TransMedics Group Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 8 days ago

TransMedics Group Earnings Call Transcript: Q1 2026

TransMedics Reports First Quarter 2026 Financial Results

May 5, 2026, 4:05 PM EDT - 8 days ago

TransMedics Reports First Quarter 2026 Financial Results

TransMedics signs agreement to invest in PAD Aviation

2026-04-29T16:43:22.000Z - 14 days ago

TransMedics signs agreement to invest in PAD Aviation

TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH

Apr 29, 2026, 9:26 AM EDT - 14 days ago

TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH

TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting

Apr 23, 2026, 7:00 AM EDT - 20 days ago

TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting

TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026

Apr 21, 2026, 4:05 PM EDT - 22 days ago

TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026

TransMedics price target lowered to $118 from $170 at Evercore ISI

2026-04-06T12:44:10.000Z - 5 weeks ago

TransMedics price target lowered to $118 from $170 at Evercore ISI

TransMedics Group Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 16, 2026, 10:00 AM EDT - 2 months ago

TransMedics Group Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

TransMedics price target raised to $130 from $115 at Stifel

2026-03-09T11:16:04.000Z - 2 months ago

TransMedics price target raised to $130 from $115 at Stifel

TransMedics Group Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 1:50 PM EST - 2 months ago

TransMedics Group Transcript: TD Cowen 46th Annual Health Care Conference

TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results

Feb 27, 2026, 7:00 AM EST - 2 months ago

TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results

TransMedics price target raised to $168 from $154 at Baird

2026-02-25T14:18:14.000Z - 2 months ago

TransMedics price target raised to $168 from $154 at Baird

TransMedics price target raised to $170 from $155 at Evercore ISI

2026-02-25T13:37:45.000Z - 2 months ago

TransMedics price target raised to $170 from $155 at Evercore ISI

TransMedics price target raised to $170 from $155 at Evercore ISI

2026-02-25T13:29:55.000Z - 2 months ago

TransMedics price target raised to $170 from $155 at Evercore ISI

TransMedics price target raised to $175 from $150 at Oppenheimer

2026-02-25T13:21:30.000Z - 2 months ago

TransMedics price target raised to $175 from $150 at Oppenheimer

TransMedics price target raised to $149 from $114 at JPMorgan

2026-02-25T12:51:49.000Z - 2 months ago

TransMedics price target raised to $149 from $114 at JPMorgan

TransMedics price target raised to $160 from $140 at Piper Sandler

2026-02-25T12:20:25.000Z - 2 months ago

TransMedics price target raised to $160 from $140 at Piper Sandler

TransMedics Group Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 2 months ago

TransMedics Group Earnings Call Transcript: Q4 2025

TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 24, 2026, 4:05 PM EST - 2 months ago

TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 20, 2026, 4:05 PM EST - 2 months ago

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

TransMedics to Present at Upcoming March Investor Conferences

Feb 17, 2026, 4:05 PM EST - 3 months ago

TransMedics to Present at Upcoming March Investor Conferences

TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Feb 10, 2026, 4:05 PM EST - 3 months ago

TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

Feb 9, 2026, 8:00 AM EST - 3 months ago

TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

These under-the-radar stocks combine fast growth with big upside potential

Jan 15, 2026, 10:31 AM EST - 4 months ago

These under-the-radar stocks combine fast growth with big upside potential

AGYS ASTH BBT CORT CTRE DCOM DOCN

TransMedics Group Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 6:00 PM EST - 4 months ago

TransMedics Group Transcript: 44th Annual J.P. Morgan Healthcare Conference

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

Jan 12, 2026, 8:10 AM EST - 4 months ago

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 4:05 PM EST - 4 months ago

TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

TransMedics Group Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 9:30 AM EST - 5 months ago

TransMedics Group Transcript: Piper Sandler 37th Annual Healthcare Conference

TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 4:05 PM EST - 6 months ago

TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

TransMedics Group Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 7 months ago

TransMedics Group Earnings Call Transcript: Q3 2025

TransMedics Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 4:05 PM EDT - 7 months ago

TransMedics Reports Third Quarter 2025 Financial Results

TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025

Oct 15, 2025, 4:05 PM EDT - 7 months ago

TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025

TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy

Sep 22, 2025, 2:00 AM EDT - 8 months ago

TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy

TransMedics Group Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 12:15 PM EDT - 8 months ago

TransMedics Group Transcript: Baird Global Healthcare Conference 2025

TransMedics Group Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 10:00 AM EDT - 8 months ago

TransMedics Group Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

TransMedics to Present at Upcoming September Investor Conferences

Aug 25, 2025, 4:05 PM EDT - 9 months ago

TransMedics to Present at Upcoming September Investor Conferences

Technical Tuesday: SPX All-Time High, OKLO Bull Flags & TMDX Bullish SMA

Aug 12, 2025, 8:00 PM EDT - 9 months ago

Technical Tuesday: SPX All-Time High, OKLO Bull Flags & TMDX Bullish SMA

OKLO

TransMedics Group Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 12, 2025, 11:30 AM EDT - 9 months ago

TransMedics Group Transcript: Canaccord Genuity’s 45th Annual Growth Conference

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

Aug 4, 2025, 8:00 AM EDT - 10 months ago

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

TransMedics Group Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 10 months ago

TransMedics Group Earnings Call Transcript: Q2 2025

TransMedics Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:05 PM EDT - 10 months ago

TransMedics Reports Second Quarter 2025 Financial Results

TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 4:05 PM EDT - 10 months ago

TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

This Company Transports Donated Organs. Its Stock Has Had a Roller-Coaster Ride.

Jul 23, 2025, 4:17 PM EDT - 10 months ago

This Company Transports Donated Organs. Its Stock Has Had a Roller-Coaster Ride.

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Jul 16, 2025, 4:05 PM EDT - 10 months ago

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

TransMedics Group Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 8:00 AM EDT - 1 year ago

TransMedics Group Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

TransMedics Group Transcript: 45th Annual William Blair Growth Stock Conference

Jun 3, 2025, 5:00 PM EDT - 1 year ago

TransMedics Group Transcript: 45th Annual William Blair Growth Stock Conference

TransMedics to Present at Upcoming June Investor Conferences

May 20, 2025, 4:05 PM EDT - 1 year ago

TransMedics to Present at Upcoming June Investor Conferences

TransMedics Group Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

TransMedics Group Earnings Call Transcript: Q1 2025

TransMedics Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 1 year ago

TransMedics Reports First Quarter 2025 Financial Results

TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 1 year ago

TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025

TMDX STOCK FRAUD: Did TransMedics Group Commit Securities Fraud? Investors are Notified to Contact BFA Law by the April 15 Court Deadline (NASDAQ:TMDX)

Apr 11, 2025, 7:43 AM EDT - 1 year ago

TMDX STOCK FRAUD: Did TransMedics Group Commit Securities Fraud? Investors are Notified to Contact BFA Law by the April 15 Court Deadline (NASDAQ:TMDX)

Gemology
Gemology May. 13 at 9:37 PM
$HUT $SLNH $TMDX $FTNT $KULR think
0 · Reply
BonprixUltimateGuardians
BonprixUltimateGuardians May. 13 at 8:07 PM
$MBAI $TMDX $DUOL $FSLY home
0 · Reply
john565
john565 May. 13 at 7:52 PM
$TMDX only works as a small position. Otherwise the volatility will mess with your head
1 · Reply
approved_13
approved_13 May. 13 at 7:41 PM
$TMDX here long term not calling under 120$ loaded 500 shares on today’s discount.
0 · Reply
rel5
rel5 May. 13 at 7:19 PM
$TMDX amazing move today, great setup $META $SOFI $BABA
0 · Reply
danieltanner
danieltanner May. 13 at 7:14 PM
$TMDX anyone read their comments for the OpO proposed rule? So well done! Certainly a big catalyst
1 · Reply
undyingzor
undyingzor May. 13 at 6:38 PM
$TMDX eps down yesr over year, quarter to quarter. It's no longer the hyper growth compsny we are used to, and may not even be a groeth company. The sector has a solid based butbshould notnbe pricing as such high prices. A p/e of 10 or around $44/share is a fair value
1 · Reply
danieltanner
danieltanner May. 13 at 6:29 PM
$TMDX how many long-term holders got shaken out of his name? How many will regret the institutions taking their shares? People complain about “the rich” get richer. They simply don’t get shaken out and look long term. We got this team!
0 · Reply
yourock
yourock May. 13 at 6:00 PM
$TMDX time to buy? 2B market cap sounds reasonable
0 · Reply
buylowandwait
buylowandwait May. 13 at 5:47 PM
$TMDX Bought more today. I don’t see fundamental shift that deserves 50% haircut. Just look at historical price, this will bounce back, once it does, it will do so violently LoL
0 · Reply
ariahhhna
ariahhhna May. 13 at 5:39 PM
$TMDX started a position. Generational wealth opportunity here at $2 billion market cap:
0 · Reply
thelattehq
thelattehq May. 13 at 4:53 PM
$TMDX https://www.thelattehq.com/p/tmdx-could-be-one-of-the-most-asymmetric-healthcare-bets-right-now
0 · Reply
rel5
rel5 May. 13 at 4:18 PM
$TMDX new position here Added more to $META $LMND
0 · Reply
3dancers
3dancers May. 13 at 4:13 PM
$TMDX this is over 40% down from earnings. It was not that bad
0 · Reply
ssdsddssd2
ssdsddssd2 May. 13 at 4:00 PM
$TMDX The market value of this stock is more than $100 - I'm buying more shares now
0 · Reply
trader_q
trader_q May. 13 at 2:39 PM
$TMDX this closes green eod. Gl all.
2 · Reply
Cycy123
Cycy123 May. 13 at 2:00 PM
$TMDX added
0 · Reply
ssdsddssd2
ssdsddssd2 May. 13 at 1:51 PM
$TMDX The stock is falling because of oil prices. As soon as oil drops, the stock doubles. I buy more.
1 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises May. 13 at 1:49 PM
$TMDX cut half my losses.
1 · Reply
TonySoprano1987
TonySoprano1987 May. 13 at 1:38 PM
$TMDX $35 as support ? Maybe then some insider buys....
1 · Reply
Lambster2
Lambster2 May. 13 at 11:13 AM
$TMDX TransMedics (NASDAQ: TMDX) Buy (1) ESG Score: 63/100 Price Target: $120.00 TD Cowen Call: Key Drivers Are On Track; IDE Approvals Are Likely Q3 Milestones THE TD COWEN INSIGHT CEO Waleed Hassanein joined us Monday for a discussion of Q1, the guidance and outlook for 2026, and the numerous growth drivers lined up for H2'26 and beyond. We summarize our conversation by topic below. The main takeaway is that the Q1 results do not reflect the many growth drivers that should soon kick in, starting with the IDE amendment approvals expected for Denovo and Enhance Part B in Q3.
2 · Reply